Edesa Biotech, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Edesa Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2013 to Q4 2024.
  • Edesa Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$1.62M, a 3.65% increase year-over-year.
  • Edesa Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$6.11M, a 20.9% increase year-over-year.
  • Edesa Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$6.17M, a 26.3% increase from 2023.
  • Edesa Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.37M, a 52.3% increase from 2022.
  • Edesa Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$17.5M, a 31.5% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 -$1.62M +$61.2K +3.65% Dec 31, 2024 10-Q 2025-02-14
Q3 2024 -$962K +$758K +44.1% Sep 30, 2024 10-K 2024-12-13
Q2 2024 -$1.67M +$317K +16% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$1.86M +$473K +20.3% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$1.68M +$656K +28.1% Dec 31, 2023 10-Q 2025-02-14
Q3 2023 -$1.72M +$1.09M +38.9% Sep 30, 2023 10-K 2024-12-13
Q2 2023 -$1.98M +$3.8M +65.7% Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$2.33M +$2.23M +48.9% Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$2.33M +$2.04M +46.7% Dec 31, 2022 10-Q 2024-02-09
Q3 2022 -$2.81M +$872K +23.7% Sep 30, 2022 10-K 2023-12-15
Q2 2022 -$5.79M -$1.03M -21.6% Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$4.57M -$2.31M -102% Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$4.38M -$1.74M -66% Dec 31, 2021 10-Q 2023-02-10
Q3 2021 -$3.69M -$1.67M -83% Sep 30, 2021 10-K 2022-12-16
Q2 2021 -$4.76M -$2.99M -170% Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$2.26M -$770K -51.7% Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$2.64M -$1.54M -141% Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$2.01M Sep 30, 2020 10-K 2021-12-28
Q2 2020 -$1.77M -$472K -36.5% Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$1.49M -$961K -182% Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$1.09M -$729K -200% Dec 31, 2019 10-Q 2021-02-16
Q2 2019 -$1.29M -$882K -214% Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$529K +$824K +60.9% Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$365K +$1.04M +74% Dec 31, 2018 10-Q 2020-02-13
Q2 2018 -$412K +$809K +66.3% Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$1.35M -$249K -22.5% Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$1.4M +$84.9K +5.72% Dec 31, 2017 10-Q 2019-02-05
Q3 2017 -$1.22M +$120K +8.97% Sep 30, 2017 10-K 2018-11-30
Q2 2017 -$1.22M -$26.3K -2.2% Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$1.1M -$243K -28.2% Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$1.49M +$144K +8.84% Dec 31, 2016 10-Q 2018-02-07
Q3 2016 -$1.34M +$196K +12.8% Sep 30, 2016 10-K 2017-12-01
Q2 2016 -$1.19M -$1.66M -357% Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$861K -$435K -102% Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$1.63M -$286K -21.3% Dec 31, 2015 10-Q 2017-02-06
Q3 2015 -$1.54M -$2.67M -236% Sep 30, 2015 10-K 2017-12-01
Q2 2015 $464K -$2.94M -86.4% Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$426K +$1.01M +70.3% Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$1.34M +$4.23M +75.9% Dec 31, 2014 10-Q 2016-02-08
Q3 2014 $1.13M +$1.37M Sep 30, 2014 10-K 2016-12-14
Q2 2014 $3.41M Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$1.43M Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$5.58M Dec 31, 2013 10-Q 2015-02-09
Q3 2013 -$240K Sep 30, 2013 10-Q 2015-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.